Senti Biosciences (SNTI) Earnings Date, Estimates & Call Transcripts $1.54 -0.15 (-8.88%) Closing price 04:00 PM EasternExtended Trading$1.58 +0.04 (+2.92%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Senti Biosciences Earnings Summary Senti Biosciences released Q2 2025 earnings on August 7, 2025, reporting an EPS of -$0.56, which topped the consensus estimate of -$0.58 by $0.02. Quarterly revenue was reported to be $0.50 million, below the consensus estimate of $1.30 million. With a trailing EPS of -$10.84, Senti Biosciences' earnings are expected to grow next year, from ($14.54) to ($1.88) per share. Latest Q2 Earnings DateAug. 7EstimatedConsensus EPS (Aug. 7) -$0.58 Actual EPS (Aug. 7) -$0.56 Beat By $0.02 Actual Revenue (Aug. 7) $0.50MQ2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)SEC FilingPowered by Get Senti Biosciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Senti Biosciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSNTI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SNTI Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Senti Biosciences Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($14.54) EPSNext Year EPS Consensus Estimate ($1.88) EPS Senti Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025-$0.58-$0.56+$0.02-$0.56$1.30M$0.50M5/6/2025Q1 2025-$0.56-$1.41 -$0.85-$1.41$1.30M$1.30M3/20/2025Q4 2024-$3.13-$0.67+$2.46-$0.67$2.80M$5.86M8/13/2024Q2 2024--$2.45--$2.45--5/9/2024Q1 2024--$2.60--$0.26--3/21/2024Q4 2023--$4.20--$0.42--11/13/2023Q3 2023-$4.80-$2.50+$2.30-$0.16$0.94M$0.34M8/11/2023Q2 2023-$4.80-$4.20+$0.60-$0.42$1.29M$0.94M Senti Biosciences Earnings - Frequently Asked Questions When is Senti Biosciences' earnings date? Senti Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 7th, 2025 based off last year's report dates. Learn more on SNTI's earnings history. Did Senti Biosciences beat their earnings estimates last quarter? In the previous quarter, Senti Biosciences (NASDAQ:SNTI) reported ($0.56) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.58) by $0.02. Learn more on analysts' earnings estimate vs. SNTI's actual earnings. How can I view Senti Biosciences' earnings report? Senti Biosciences' earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Senti Biosciences generate each year? Senti Biosciences (NASDAQ:SNTI) has a recorded annual revenue of $2.56 million. How much profit does Senti Biosciences generate each year? Senti Biosciences (NASDAQ:SNTI) has a recorded net income of -$52.79 million. SNTI has generated -$10.84 earnings per share over the last four quarters. What is Senti Biosciences' EPS forecast for next year? Senti Biosciences' earnings are expected to grow from ($14.54) per share to ($1.88) per share in the next year. More Earnings Resources from MarketBeat Related Companies Eupraxia Pharmaceuticals Earnings Date CytomX Therapeutics Earnings Date Eledon Pharmaceuticals Earnings Date enGene Earnings Date Kyverna Therapeutics Earnings Date Galectin Therapeutics Earnings Date Aclaris Therapeutics Earnings Date Lyell Immunopharma Earnings Date Cybin Earnings Date Voyager Therapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a RallyRivian Takes Earnings Hit—R2 Could Be the Stock's 2026 LifelinePalantir Stock Soars After Blowout Earnings ReportVertical Aerospace's New Deal and Earnings De-Risk Production This page (NASDAQ:SNTI) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senti Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senti Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
